It is conceivable that a decrease in the binding affinity of IGF-1 LR3 for IGFBPs might affect its bioavailability, potentially reducing its duration of action
In this study, systolic blood pressure, triglyceride levels, and non-HDL cholesterol levels significantly improved with orforglipron treatment compared to placebo
Not everyone responds to GLP-1 medications the same wayit's biology, not a personal failing
Kim LC, Song L, Haura EB
Sergey Terushkin, MD, FACS is a fellowship-trained bariatric and general surgeon with experience in bariatric surgery, revisional bariatric surgery, medical weight loss, robotic surgery, and post-weight-loss surgical care
If your Phenotypic Age is equal to or higher than your chronological age, you have the opportunity to make improvements to your lifestyle, environment, and/or adherence to longevity protocols